Click on graphic to open larger version.
Bedaqualine (BDQ) is the first new class of antibiotic to come along in decades. Here’s how it’s being introduced to treat drug-resistant TB in many low- and middle-income countries. Scroll over the photos and click for more information. [huge_it_gallery id=”1″]
SIAPS helps high-burden TB countries build their capacity, consensus, and technical skills to strengthen pharmaceutical systems and services. The end goals: Better access to essential medicines, better health outcomes—and a world without TB. Below are highlights of some key projects. The Groundbreaker: Rolling Out a New TB Drug Bedaquiline is the first new class of […]
Today SIAPS joins people around the world commemorating World TB Day. This year’s theme, “Reach the 3 million,” is a call worldwide to find, treat and cure the undetected TB cases left behind in the fight against TB. Read about the first Conference on Pharmaceutical Management for TB and M/XDR-TB for the WHO European Region, […]